Secondary Hyperparathyroidism Dialysis Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Secondary Hyperparathyroidism Dialysis
Secondary hyperparathyroidism (SHPT) is a common and serious complication for individuals undergoing dialysis, where impaired kidney function leads to an imbalance in calcium and phosphorus, overworking the parathyroid glands. Managing this condition often requires costly medications. TheDrugClub offers a simple solution, providing significant savings on these essential prescriptions, ensuring you can afford the care you need.
Secondary hyperparathyroidism (SHPT) is a prevalent and challenging condition for many individuals living with chronic kidney disease (CKD), particularly those on dialysis. Healthy kidneys play a vital role in balancing calcium and phosphorus levels in the body and activating vitamin D. When kidneys fail, these functions are severely compromised. Phosphorus levels can rise, and the body produces less active vitamin D, leading to a drop in blood calcium.
In response to low calcium and high
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.